Related Experiment Video
Updated: Jul 19, 2026
10:00
High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
Systemic lupus erythematosus: all roads lead to type I interferons
Virginia Pascual1, Lorant Farkas, Jacques Banchereau
1Baylor Institute for Immunology Research, 3434 Live Oak Street, Suite 205, Dallas, TX 75204, USA. virginip@baylorhealth.edu
Current Opinion in Immunology
|October 3, 2006
Summary
Type I interferon (IFN) drives systemic lupus erythematosus (SLE) by activating immune cells and hindering tolerance. Targeting IFN offers a promising new therapeutic strategy for SLE patients.
Area of Science:
- Immunology
- Rheumatology
- Molecular Biology
Background:
- Systemic lupus erythematosus (SLE) pathogenesis involves complex immune dysregulation.
- Type I interferon (IFN) has emerged as a key player in SLE development and progression.
Purpose of the Study:
- To elucidate the specific mechanisms by which type I IFN contributes to SLE pathogenesis.
- To explore the therapeutic potential of targeting the type I IFN pathway in SLE.
Main Methods:
- Analysis of immune cell activation in SLE patients.
- Investigation of IFN's direct and indirect effects on T cells and B cells.
- Examination of genetic factors (e.g., IRF5) influencing IFN production and signaling.
Main Results:
- Type I IFN promotes aberrant activation of dendritic cells, leading to autoreactive T cell activation and loss of peripheral tolerance.
- IFN directly impacts T cell and B cell function in SLE.
- Immune complexes amplify IFN production and B cell activation via FcgammaR and Toll-like receptors.
- Genetic variations in IFN-related genes may underlie SLE alterations.
Conclusions:
- Type I IFN is a critical driver of SLE pathogenesis through multiple immune cell interactions.
- IFN antagonists represent a promising therapeutic avenue for managing SLE.
Related Concept Videos
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:27Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...